Genomic insights into cancer-associated aberrant CpG island hypermethylation

Carcinogenesis is thought to occur through a combination of mutational and epimutational events that disrupt key pathways regulating cellular growth and division. The DNA methylomes of cancer cells can exhibit two striking differences from normal cells; a global reduction of DNA methylation levels a...

Full description

Bibliographic Details
Main Authors: Sproul, Duncan, Meehan, Richard R.
Format: Online
Language:English
Published: Oxford University Press 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662888/
id pubmed-3662888
recordtype oai_dc
spelling pubmed-36628882013-05-24 Genomic insights into cancer-associated aberrant CpG island hypermethylation Sproul, Duncan Meehan, Richard R. Papers Carcinogenesis is thought to occur through a combination of mutational and epimutational events that disrupt key pathways regulating cellular growth and division. The DNA methylomes of cancer cells can exhibit two striking differences from normal cells; a global reduction of DNA methylation levels and the aberrant hypermethylation of some sequences, particularly CpG islands (CGIs). This aberrant hypermethylation is often invoked as a mechanism causing the transcriptional inactivation of tumour suppressor genes that directly drives the carcinogenic process. Here, we review our current understanding of this phenomenon, focusing on how global analysis of cancer methylomes indicates that most affected CGI genes are already silenced prior to aberrant hypermethylation during cancer development. We also discuss how genome-scale analyses of both normal and cancer cells have refined our understanding of the elusive mechanism(s) that may underpin aberrant CGI hypermethylation. Oxford University Press 2013-05 2013-01-21 /pmc/articles/PMC3662888/ /pubmed/23341493 http://dx.doi.org/10.1093/bfgp/els063 Text en © The Author 2013. Published by Oxford University Press. http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Sproul, Duncan
Meehan, Richard R.
spellingShingle Sproul, Duncan
Meehan, Richard R.
Genomic insights into cancer-associated aberrant CpG island hypermethylation
author_facet Sproul, Duncan
Meehan, Richard R.
author_sort Sproul, Duncan
title Genomic insights into cancer-associated aberrant CpG island hypermethylation
title_short Genomic insights into cancer-associated aberrant CpG island hypermethylation
title_full Genomic insights into cancer-associated aberrant CpG island hypermethylation
title_fullStr Genomic insights into cancer-associated aberrant CpG island hypermethylation
title_full_unstemmed Genomic insights into cancer-associated aberrant CpG island hypermethylation
title_sort genomic insights into cancer-associated aberrant cpg island hypermethylation
description Carcinogenesis is thought to occur through a combination of mutational and epimutational events that disrupt key pathways regulating cellular growth and division. The DNA methylomes of cancer cells can exhibit two striking differences from normal cells; a global reduction of DNA methylation levels and the aberrant hypermethylation of some sequences, particularly CpG islands (CGIs). This aberrant hypermethylation is often invoked as a mechanism causing the transcriptional inactivation of tumour suppressor genes that directly drives the carcinogenic process. Here, we review our current understanding of this phenomenon, focusing on how global analysis of cancer methylomes indicates that most affected CGI genes are already silenced prior to aberrant hypermethylation during cancer development. We also discuss how genome-scale analyses of both normal and cancer cells have refined our understanding of the elusive mechanism(s) that may underpin aberrant CGI hypermethylation.
publisher Oxford University Press
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662888/
_version_ 1611980701811343360